Drugs / Calcium Silicate

Trials 3

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT07641933 Jun 2026 → Jun 2027 expected suppurative periapical periodontitis Ain Shams University Recruiting No outcome recorded
Phase not applicable2 trials
— NCT06779370 Jun → Dec 2024 — Ataturk University Completed No outcome recorded
— NCT06307678 Jul → Dec 2023 periapical periodontitis Ataturk University Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Calcium Silicate ClinicalTrials.gov intervention name — accepted as the source's own label NCT07641933 ↗
2

NCT06779370 ↗

NCT06307678 ↗

Known as Bio-C Temp “Calcium silicate-based bioceramic Intracanal Medication as Bio C-Temp (Angelus)” NCT07641933 ↗
Known as Calcarea silicata ChEMBL registry synonym — accepted as the source's own label CHEMBL2108942 ↗
Known as E-552 ChEMBL registry synonym — accepted as the source's own label CHEMBL2108942 ↗
Known as Huberderm 1000 ChEMBL registry synonym — accepted as the source's own label CHEMBL2108942 ↗
Known as INS NO.552 ChEMBL registry synonym — accepted as the source's own label CHEMBL2108942 ↗
Known as INS-552 ChEMBL registry synonym — accepted as the source's own label CHEMBL2108942 ↗
Known as Silicic acid, calcium salt ChEMBL registry synonym — accepted as the source's own label CHEMBL2108942 ↗
Modality Other / unclassified “Calcium silicate-based bioceramic materials” NCT07641933 ↗
Route Other “Calcium silicate based medicament was placed in the canals using a file” NCT06307678 ↗